¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"passive diffusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive diffusion
    ¼öµ¿È®»ê
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive
    ¼öµ¿-, Çǵ¿-
  • passive aggressive personality
    ¼öµ¿°ø°ÝÀΰÝ
  • passive congestion
    ¼öµ¿¿ïÇ÷
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • passive edema
    ¼öµ¿ºÎÁ¾
  • passive euthanasia
    ¼Ò±ØÀû¾È¶ô»ç
  • passive exercise
    Çǵ¿¿îµ¿
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • passive hyperemia
    ¼öµ¿ÃæÇ÷
  • passive immunity
    ¼öµ¿¸é¿ª
  • passive immunization
    ¼öµ¿¸é¿ªÈ­
  • passive movement
    ¼öµ¿¿îµ¿, Çǵ¿¿îµ¿
  • passive observer
    ¼öµ¿°üÂûÀÚ
  • passive sensitization
    ¼öµ¿¹Î°¨È­
  • passive shimming
    ¼öµ¿º¸Á¤
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive
    ¼öµ¿-, Çǵ¿-
  • passive smoking
    °£Á¢Èí¿¬
  • diffusion
    È®»ê
  • simple diffusion
    ´Ü¼øÈ®»ê
  • diffusion time
    È®»ê½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive diffusion
    ¼öµ¿È®»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
  • passive congestion
    ¼öµ¿¿ïÇ÷
  • passive edema
    ¼öµ¿ºÎÁ¾
  • passive euthanasia
    ¼öµ¿¾È¶ô»ç
  • passive exercise
    Çǵ¿¿îµ¿
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • passive hyperemia
    ¼öµ¿ÃæÇ÷
  • reversed passive hemagglutination
    ¿ª¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • passive immunity
    ¼öµ¿¸é¿ª
  • passive immunization
    ¼öµ¿¸é¿ªÈ­
  • passive movement
    Çǵ¿¿îµ¿
  • passive observer
    ¼öµ¿°üÂûÀÚ
  • passive
    ¼öµ¿-, Çǵ¿-
  • passive sensitization
    ¼öµ¿¹Î°¨
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agglutination, passive
    ¼öµ¿ÀÀÁý
  • appreciation of passive movement
    ¼öµ¿¿îµ¿°¨°¢.
  • hemagglutination, passive
    ¼öµ¿ Ç÷±¸ÀÀÁý
  • hemagglutination, reversed passive
    ¿ª¼öµ¿ Ç÷±¸ÀÀÁý¹ÝÀÀ
  • immunity, passive
    ¼öµ¿¸é¿ª
  • immunization, passive
    ¼öµ¿¸é¿ª
  • indirect passive agglutination
    °£Á¢¼öµ¿ÀÀÁý(¹ÝÀÀ).
  • personality disorder, passive
    ¼öµ¿¼º(áôÔÑàõ) ÀΰÝÀå¾Ö
  • personality disorder, passive-aggressive
    ¼öµ¿°ø°Ý¼º ÀΰÝÀå¾Ö
  • personality, passive aggresive
    ¼öµ¿°ø°Ý¼º ÀΰÝ.
  • ADC (apparent diffusion coefficient)
    °Ñº¸±â È®»ê °è¼ö
  • Ficks law of diffusion
    ÇÈÀÇ È®»ê(üªß¤)¹ýÄ¢(ÛööÎ)
  • Oudins agar diffusion
    ¿ìµ­ ÇÑõȮ»ê¹ý
  • agar diffusion
    ÇÑõ(³»)È®»ê(¡­üªß¤).
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive diffusion
    ¼öµ¿Àû È®»ê(¡­îÜüªß¤).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agglutination, passive
    ¼öµ¿ÀÀÁý
  • appreciation of passive movement
    ¼öµ¿¿îµ¿°¨°¢.
  • congestion,chronic passive
    ¸¸¼º Çǵ¿¼º(Ø·àõù¬ÔÑàõ)
  • downhill transport =passive t.
    Çǵ¿¿î¹Ý(ù¬ÔÑê¡Úæ).
  • hemagglutination, passive
    ¼öµ¿ Ç÷±¸ÀÀÁý
  • hemagglutination, reversed passive
    ¿ª¼öµ¿ Ç÷±¸ÀÀÁý¹ÝÀÀ
  • immunity, passive
    ¼öµ¿¸é¿ª
  • immunization, passive
    ¼öµ¿¸é¿ª
  • indirect passive agglutination
    °£Á¢¼öµ¿ÀÀÁý(¹ÝÀÀ).
  • passive agglutination
    ¼öµ¿ÀÀÁý
  • passive agglutination
    ¼öµ¿ÀÀÁý(¡­ëêó¢). (Á¤½Å)¼öµ¿ÀÇÁ¸¼º(ÀÇ).
  • passive aggressive
    Çǵ¿°ø°Ý¼º, ¼öµ¿°ø°ÝÀû.
  • passive anaphylaxis
    Çǵ¿Àû(ù¬ÔÑîÜ)¾Æ³ªÇʶô½Ã.
  • passive anaphylaxis
    Çǵ¿Àû(ù¬ÔÑîÜ)¾Æ³ªÇʶô½Ã½º.
  • passive carrier
    ¼öµ¿º¸±ÕÀÚ(ËÛËÄËÓË»Ëö).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive diffusion
    ¼öµ¿ È®»ê(áôÔÑüªß¤)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive agglutination
    ¼öµ¿ ÀÀÁý(áôÔÑëêó¢)
  • passive anaphylaxis
    ¼öµ¿(áôÔÑ) ¾Æ³ªÇʶô½Ã½º
  • passive hemagglutination
    ¼öµ¿ Ç÷¾×ÀÀÁý(áôÔÑúìäûëêó¢)
  • passive hemolysis
    ¼öµ¿¿ëÇ÷(áôÔÑéÁúì)
  • passive immunity
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹)
  • passive mediated transport
    ¼öµ¿ ¸Å°³¿î¹Ý(áôÔÑØÚË¿ê¡Úæ)
  • passive spread
    ¼öµ¿ ÀüÆÄ(áôÔÑîî÷ë)
  • passive transfer
    ¼öµ¿ À̵¿(áôÔÑì¹ÔÑ)
  • passive transport
    ¼öµ¿ ¼ö¼Û(áôÔÑâÃáê)
  • agar diffusion method
    ÇÑõȮ»ê¹ý(ùÎô¸üªß¤Ûö)
  • carrier-facilitated diffusion
    ij¸®¾î ÃËÁø È®»ê(õµòäüªß¤)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • diffusion
    È®»ê(üªß¤)
  • diffusion chamber
    È®»ê½Ç(üªß¤ãø)
  • diffusion coefficient
    È®»ê°è¼ö(üªß¤Ìõâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive
    Çǵ¿ÀÇ, ¼öµ¿ÀÇ, ¼Ò±ØÀûÀÎ
  • passive movement
    ¼öµ¿¿îµ¿, Çǵ¿¿îµ¿
  • passive shimming
    ¼öµ¿º¸Á¤
  • ADC [=apparent diffusion coefficient]
    °Ñº¸±âÈ®»ê°è¼ö
  • anisotropic diffusion
    ºñµî¹æ¼ºÈ®»ê
  • apparent diffusion coefficient [=ADC]
    °Ñº¸±âÈ®»ê°è¼ö
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • diffusion
    È®»ê, ¹Ì»ê
  • diffusion coefficient
    È®»ê°è¼ö
  • diffusion equation
    È®»êµî½Ä
  • diffusion gradient pulse
    È®»ê°æ»çÆÞ½º
  • diffusion imaging
    È®»ê¿µ»ó
  • diffusion spectroscopy
    È®»êºÐ±¤¹ý
  • diffusion tensor imaging [=DTI]
    È®»êÅÙ¼­¿µ»ó
  • diffusion time
    È®»ê½Ã°£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGD agar gel diffusion; agarose diffusion; alpha-ketoglutarate dehydrogenase
DP data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de...
PCA   1) Passive Cutaneous Araphylaxis
  2) Posterior Cerebral Artery
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CPM Continuous passive motion
FPT Failure of passive transfer
PAR Passive Anterior Rhinomanometry
PAR Passive Avoidance Response
PCA Passive Cutaneous Anaphylaxis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • continuous passive motion
    Áö¼ÓÀûÀÎ ¼öµ¿ ¿îµ¿, °è¼ÓÀûÀÎ ¼öµ¿ ¿îµ¿, Áö¼ÓÀûÀÎ ¼öµ¿Àû ¿îµ¿
    Á¤ÇØÁø ¿îµ¿ ¹üÀ§³»·Î °üÀýÀ» ¿òÁ÷ÀÌ´Â ±â°è³ª ´Ù¸¥ »ç¶÷¿¡ ÀÇÇØ ÀÌ·ç¾îÁö´Â ½ÅüÀÇ ÁÖ±âÀûÀÎ ¿îµ¿.
  • passive agglutination
    ¼öµ¿ ÀÀÁý
  • passive dependent
    Çǵ¿ ÀÇÁ¸¼º. ¼öµ¿ ÀÇÁ¸¼ºÀÇ
  • passive edema
    ¼öµ¿ ºÎÁ¾
  • passive exercise
    ¼öµ¿Àû ¿îµ¿
  • passive hemagglutination
    Çǵ¿¼º ÀûÇ÷±¸ ÀÀÁý
  • passive hyperemia
    ¼öµ¿¼º ÃæÇ÷
  • passive movement
    ¼öµ¿ ¿îµ¿, Çǵ¿ ¿îµ¿
  • passive muscle stretching
    ¼öµ¿Àû ±Ù ½ÅÀå
  • passive range of motion
    ¼öµ¿Àû ¿îµ¿ ¹üÀ§
    ´Ù¸¥ »ç¶÷À̳ª ±â°è ¶Ç´Â ¿ÜºÎÀÇ Èû¿¡ ÀÇÇÏ¿© ±³ÇÕ, °ü·Ã °üÀý³¶, Àδë, ±ÙÀ°À¸·Î Àü´ÞµÈ ¿îµ¿.
  • passive resistive stretch
    ¼öµ¿Àû ÀúÇ× ½ÅÀü
    ¹Ý´ëµÇ´Â Èû¿¡ ´ëÇÏ¿© ±ÙÀ°À» Ȱ¼ºÈ­½ÃŲ ´ÙÀ½ ½ÅÀü½ÃÅ´À¸·Î¼­ ±ÙÀ°ÀÇ ±æÀ̸¦ Áõ°¡Çϵµ·Ï °í¾ÈµÈ ¿îµ¿.
  • passive stretch
    ¼öµ¿Àû ½ÅÀå, ¼öµ¿Àû ½ÅÀü
  • passive stretching
    ¼öµ¿Àû ½ÅÀå
  • passive transport
    Çǵ¿Àû ¿î¹Ý, Çǵ¿Àû À̵¿, ¼öµ¿Àû À̵¿
  • passive-aggressive personality
    ¼öµ¿Àû °ø°Ý¼º ÀΰÝ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
passive diffusion See: facilitated transport.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ambipolar diffusion <radiobiology> Diffusion process in which buildup of spatial charge creates electric fields which cause electrons and ions to leave the plasma at the same rate. (Such electric fields are self-generated by the plasma and act to preserve charge neutrality.)
(09 Oct 1997)
anomalous diffusion <radiobiology> Diffusion in most plasma devices, particularly tokamaks, is higher than what one would predict from understood causes. The observed, typical diffusion is referred to as anomalous because it has not yet been explained.
Anomalous diffusion includes all diffusion which is not due to collisions and geometric effects. While such effects were not understood when the term was coined, and most still are not, diffusion due to well-understood wave phenomena is still 'anomalous'. Classical diffusion and Neo-classical diffusion are the two well-understood diffusion theories, although neither is adequate to fully explain the observed anomalous diffusion.
See: entries for classical diffusion and neoclassical diffusion. Anomalous resistivity
(09 Oct 1997)
bohm diffusion <radiobiology> A rapid loss of plasma across magnetic field lines caused by microinstabilities. Theory formulated by the physicist David Bohm.
Semiempirical formula for the diffusion coefficient given by Bohm in 1946 (noted by Bohm, Burhop, and Massey, who were developing a magnetic arc for use in uranium isotope separation). Bohm diffusion was proposed (not derived from first principles) to scale as 1/B rather than the 1/B^2 scaling predicted by classical diffusion. A 1/B scaling results from assuming that particles diffuse across field lines at an optimum rate (effective collision frequency=cyclotron frequency). The 1/B scaling is observed (approximately) in most reactors.
See: diffusion, microinstabilities, field lines.
(09 Oct 1997)
gel diffusion Diffusion in a gel, as in the case of gel diffusion precipitin tests in which the immune reactants diffuse in agar.
See: immunodiffusion.
(05 Mar 2000)
gel diffusion precipitin tests Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
gel diffusion precipitin tests in one dimension Precipitin test's in which antigen solution and antibody incorporated in agar are layered in tubes, permitting effective diffusion in the vertical dimension; the antibody-containing agar may be overlaid directly with antigen solution (single (gel) diffusion in one dimension).
(05 Mar 2000)
gel diffusion precipitin tests in two dimensions Precipitin test's made in a layer of agar that permits radial diffusion, in both of the horizontal dimensions, of one or both reactants. Double (gel) diffusion in two dimensions (Ouchterlony test, technique, or method) incorporates antigen and antibody solutions placed in separate wells in a sheet of plain agar, permitting radial diffusion of both reactants; this method is widely used to determine antigenic relationships; the bands of precipitate that form where the reactants meet in optimal concentration are of three patterns, referred to as reaction of identity, reaction of partial identity (cross-reaction), and reaction of nonidentity.
(05 Mar 2000)
gel diffusion reactions Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
classical diffusion <radiobiology> In plasma physics, diffusion due solely to scattering (collisions) of charged particles (with unlike charges) via electrical (Coulomb) interactions. (See also diffusion.)
(09 Oct 1997)
population diffusion coefficient <cell biology> Coefficient that describes the tendency of a population of motile cells to diffuse through the environment. Its use presupposes that the cells move in a random walk.
(18 Nov 1997)
neoclassical diffusion <radiobiology> In a magnetised plasma, _classical_ diffusion refers to transport of particles due to Coulomb collisions, taking the spiral orbits in the magnetic field into account. In a toroidal magnetic field, the actual rate of diffusive transport is much higher due to slow changes in the positions of the centres of the spirals, known as banana orbits.
This faster transport is called _neo-classical_. With very few exceptions the transport in toroidal devices is observed to be 10-100 times larger still, presumably due to small-scale turbulence. The observed transport is called _anomalous_ (although it actually is the normal state).
(09 Oct 1997)
diffusion The process of becoming diffused or widely spread, the spontaneous movement of molecules or other particles in solution, owing to their random thermal motion, to reach a uniform concentration throughout the solvent, a process requiring no addition of energy to the system.
(18 Nov 1997)
diffusion anoxia Diffusion hypoxia severe enough to result in the absence of oxygen in alveolar gas.
(05 Mar 2000)
diffusion chambers, culture Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.
(12 Dec 1998)
diffusion coefficient For the translational diffusion of solutes, diffusion is described by Fick's First Law, that states that the amount of a substance crossing a given area is proportional to the spatial gradient of concentration and the diffusion constant (D), that is related to molecular size and shape. A useful derived relationship is that the mean square distance moved by molecules in time t is 6Dt.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffusion
    È®»ê
  • diffusion
    »êÆ÷;À¯Æ÷;º¸±Þ;»ê¸¸
  • diffusion index
    È®»ê Áö¼ö;°æ±â µ¿Çâ Áö¼ö
  • diffusion pump
    È®»ê Áø°ø ÆßÇÁ(°¡½ºÀÇ È®»êÀ» ÀÌ¿ëÇÏ¿© ³ôÀº Áø°øµµ¸¦ ¸¸µê)
  • gaseous diffusion
    ±âü È®»ê¹ý
  • passive
    ¼öµ¿¼ºÀÇ; ¼ø¼øÈ÷ µû¸£´Â
  • passive
    ¼öµ¿ÀÇ;¹«ÀúÇ×ÀÇ;Ȱ¹ßÇÏÁö ¸øÇÑ
  • passive belt
    ÀÚµ¿ ¾ÈÀü ¹ëÆ®
  • passive euthanasia
    ¼Ò±ØÀû ¾È¶ô»ç
  • passive immunity
    ¼öµ¿ ¸é¿ª
  • passive immunization
    ¼öµ¿ ¸é¿ª
  • passive obedience
    Àý´ë º¹Á¾;¹¬Á¾
  • passive resistance
    ¼Ò±ØÀû ÀúÇ×
  • passive resister
    ¼Ò±ØÀû ÀúÇ×ÀÚ
  • passive restraint
    ¼öµ¿Àû ¾ÈÀüÀåÄ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á